
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.
Click the title above to open the Pharmaceutical Executive July 2017 issue in an interactive PDF format.
over 9 years ago
Building a Digital Health Infrastructureover 9 years ago
Patient Insights in the Age of AIover 9 years ago
Pharma Raises Stakes in Digital Healthover 9 years ago
Removing Uncertainty from the Drug Insurance Conversationover 9 years ago
Reflections from DIAover 9 years ago
Can AI Improve Sales Productivity in Pharma?over 9 years ago
Improving Patients’ Lives and Boosting Mature Product Portfoliosover 9 years ago
Reinventing the Role of Medical Affairsover 9 years ago
Beyond KOL Marketing: Tapping Digital Opinion Influencersover 9 years ago
There’s a Digital Health App for That!





